Alexey M Belkin Selected Research

NDSK-II

11/2016

Anti-VLDL receptor monoclonal antibodies inhibit fibrin-VLDL receptor interaction and reduce fibrin-dependent leukocyte transmigration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexey M Belkin Research Topics

Disease

3	Inflammation (Inflammations) 11/2016 - 05/2005
3	Neoplasms (Cancer) 04/2014 - 09/2004
2	Neoplasm Metastasis (Metastasis) 06/2015 - 01/2012
2	Melanoma (Melanoma, Malignant) 06/2015 - 02/2015
2	Vascular Diseases (Vascular Disease) 05/2012 - 09/2011
1	Peritonitis 11/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2016
1	Reperfusion Injury 11/2016
1	Nevus (Nevi) 06/2015
1	Neointima 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Fibrosis (Cirrhosis) 01/2012
1	Vascular Remodeling 01/2012
1	Atherosclerosis 09/2011
1	Vascular Calcification 09/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2015 - 09/2011
3	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2014 - 09/2011
2	FibrinIBA 11/2016 - 05/2005
2	Fibronectins (Fibronectin)IBA 06/2015 - 02/2015
1	Monoclonal AntibodiesIBA 11/2016
1	NDSK-IIIBA 11/2016
1	VLDL LipoproteinsIBA 11/2016
1	Messenger RNA (mRNA)IBA 06/2015
1	CateninsIBA 01/2014
1	Multifunctional EnzymesIBA 01/2013
1	Platelet-Derived Growth FactorIBA 05/2012
1	Becaplermin (PDGF-BB)FDA Link 05/2012
1	estropipate (Ogen)FDA LinkGeneric 05/2005
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2004
1	Matrix Metalloproteinases (MMPs)IBA 09/2004
1	Peptide Hydrolases (Proteases)FDA Link 09/2004

Therapy/Procedure

1	Therapeutics 11/2016
1	Ligation 01/2014